Drug Shortage Report for BIO-AMLODIPINE
| Report ID | 147158 |
| Drug Identification Number | 02392135 |
| Brand name | BIO-AMLODIPINE |
| Common or Proper name | AMLODIPINE |
| Company Name | BIOMED PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | AMLODIPINE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C08CA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2021-10-13 |
| Estimated end date | |
| Actual end date | 2021-10-25 |
| Shortage status | Resolved |
| Updated date | 2021-10-26 |
| Company comments | Nous gardons le format de 500 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-10-26 | English | Compare |
| v4 | 2021-10-25 | French | Compare |
| v3 | 2021-10-25 | English | Compare |
| v2 | 2021-10-14 | French | Compare |
| v1 | 2021-10-14 | English | Compare |
Showing 1 to 5 of 5